Cassia alata

Cassia alata contains chrysophanic acid (chrysophanol), aloe-emodin, emodin, kaempferol, and quercetin as primary bioactive compounds that exert antifungal, antibacterial, anti-inflammatory, and antioxidant effects through disruption of fungal cell membranes, free radical scavenging, and TNF-α suppression. In preclinical assays, methanol leaf extract demonstrated DPPH radical scavenging with an IC₅₀ of 54 μg/mL, while aloe-emodin achieved IC₅₀ of 12.7 ppm against MCF-7 breast cancer cells, and hexane extract inhibited α-glucosidase with IC₅₀ of 0.85 mg/mL.

Origin & History

Cassia alata L. (family Fabaceae/Leguminosae) is native to tropical Central and South America but has naturalized extensively across Southeast Asia, South Asia, and sub-Saharan Africa, thriving in disturbed soils, roadsides, and forest margins at low to mid elevations. It is widely cultivated in Indonesia, the Philippines, Malaysia, and Thailand, where it grows as a fast-maturing shrub reaching 1–3 meters in height under humid, tropical conditions with well-drained soils and full sun exposure. In Indonesia, it is a foundational ingredient in Jamu traditional medicine and is often cultivated in home gardens specifically for its leaves, which are harvested year-round for topical and internal preparations.

Historical & Cultural Context

Cassia alata has been integral to Indonesian Jamu—the archipelago's centuries-old herbal medicine system—where it is called 'daun ketepeng cina' and prescribed primarily for skin diseases including ringworm, scabies, and eczema, with its bright yellow flowers and distinctive leaf morphology making it a recognizable medicinal plant in village gardens. Across Southeast Asia, traditional healers in the Philippines (where it is called 'akapulko'), Thailand ('chaum muang'), and Malaysia ('gelenggang besar') similarly apply crushed leaves topically to fungal and bacterial skin infections, a convergent traditional use that likely reflects the high-concentration anthraquinone and flavonoid content of the fresh leaf. In Ayurvedic-adjacent systems of South Asia, the plant has historically been used as a purgative and for intestinal parasite management, exploiting the anthranoid glycoside content analogous to other senna-family plants. The species was formally described by Carl Linnaeus in the 18th century, and its widespread pan-tropical naturalization means it appears in traditional pharmacopeias from the Caribbean to West Africa under various regional names, all sharing the common application of treating dermatological infections.

Health Benefits

- **Antifungal Activity**: Chrysophanol (chrysophanic acid) and related anthraquinones in Cassia alata leaves disrupt fungal cell membrane integrity, underpinning its long-standing traditional use against dermatophytes and tinea infections such as ringworm (tinea corporis) in Indonesian Jamu practice.
- **Antioxidant Protection**: Phenolic compounds including caffeic acid, ferulic acid, and anacardic acid triene, together with flavonoids kaempferol and quercetin, scavenge free radicals and chelate pro-oxidant metal ions; methanol leaf extract achieved an IC₅₀ of 54 ± 2.20 μg/mL in DPPH assays, outperforming the BHT reference standard (72 ± 2.20).
- **Anti-Inflammatory Effects**: Chrysarobin, tannins, kaempferol, isochrysophanol, and chrysophanol glycosides suppress TNF-α production in a dose-dependent manner, with 1 mg of extract showing the most effective inhibition of IPP-induced TNF-α generation in cell-based models.
- **Antidiabetic Potential**: Five identified compounds—5-methoxyhydnocarpin-D, quercetin 3-rhamnoside-7-glucoside, marimetin, kaempferol, and emodin—inhibit the carbohydrate-digesting enzymes α-amylase (IC₅₀ = 6.41 mg/mL) and α-glucosidase (IC₅₀ = 0.85 mg/mL), suggesting postprandial glucose-lowering potential.
- **Anticancer Activity (Preclinical)**: Aloe-emodin and emodin demonstrate cytotoxicity against MCF-7 breast cancer cells (IC₅₀ 12.7 and 18.1 ppm, respectively), while ethanolic leaf extract inhibited SW1353 chondrosarcoma cell migration and invasion with IC₅₀ < 100 μg/mL while showing low toxicity to normal cells (LC₅₀ > 1000 μg/mL).
- **Hepatoprotective Effects**: In a rat model of CCl₄-induced hepatotoxicity, Cassia alata flower extract significantly reduced elevated serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels (P ≤ 0.05), suggesting hepatocellular protective capacity through antioxidant and anti-inflammatory pathways.
- **Antibacterial Activity**: Fatty acid constituents including linoleic acid, palmitic acid, stearic acid, neophytadiene, and methyl palmitate exert antibacterial activity against both gram-positive and gram-negative organisms, with GC-MS identification confirming 32 of 88 detected phytochemicals as possessing documented antibacterial properties.

How It Works

Chrysophanol and related anthraquinones (aloe-emodin, emodin) intercalate with fungal and bacterial cell membranes, increasing permeability and ultimately causing cell lysis, while also inhibiting nucleic acid synthesis in susceptible pathogens. The hydroxylated flavonoids quercetin and kaempferol act as direct radical scavengers via hydrogen atom transfer from their phenolic hydroxyl groups, and also chelate transition metal ions (Fe²⁺, Cu²⁺) through their 3-OH/4-carbonyl and catechol moieties to prevent Fenton-type oxidative reactions. Anti-inflammatory activity proceeds through dose-dependent suppression of TNF-α biosynthesis by chrysarobin and chrysophanol glycosides, and kaempferol additionally modulates NF-κB signaling to reduce pro-inflammatory cytokine transcription. Antidiabetic effects are mediated through competitive inhibition of α-glucosidase and α-amylase by emodin and kaempferol derivatives, slowing intestinal glucose absorption and blunting postprandial hyperglycemia.

Scientific Research

The evidence base for Cassia alata is composed almost entirely of in vitro cell culture assays and animal model studies, with no peer-reviewed randomized controlled trials (RCTs) in human populations identified in the current literature. Quantitative in vitro findings are consistent across multiple laboratories—DPPH antioxidant, enzyme inhibition, and cytotoxicity assays have been replicated with comparable IC₅₀ values—lending moderate internal validity to the preclinical data, though extrapolation to human efficacy remains speculative. One rat hepatotoxicity study demonstrated statistically significant reductions in AST and ALT (P ≤ 0.05) following flower extract administration post-CCl₄ challenge, representing the strongest mechanistic in vivo evidence available. The body of research is preliminary in human applicability, and well-designed phase I/II clinical trials are necessary to establish pharmacokinetics, bioavailability, effective human doses, and safety before therapeutic claims can be substantiated.

Clinical Summary

No human clinical trials with defined sample sizes, randomization, or controlled comparators have been published for Cassia alata as of the current evidence review. Available quantitative data derive from in vitro assays: antioxidant IC₅₀ values of 54 μg/mL (DPPH, methanol leaf extract), α-glucosidase inhibition IC₅₀ of 0.85 mg/mL (hexane extract), and cytotoxicity IC₅₀ values ranging from 12.7 ppm (aloe-emodin vs. MCF-7) to 160 μg/mL (n-hexane extract vs. OV2008 ovarian cancer cells). The single in vivo animal study demonstrated hepatoprotective effects with statistically significant enzyme normalization, but rodent pharmacodynamics do not reliably predict human outcomes. Confidence in clinical efficacy is low; the preclinical signal is scientifically interesting but requires human pharmacokinetic and efficacy investigation before clinical recommendations can be made.

Nutritional Profile

Cassia alata leaves contain a diverse array of phytochemicals rather than notable macro- or micronutrient concentrations relevant to dietary supplementation. Primary phytochemicals include anthraquinones (chrysophanol/chrysophanic acid, aloe-emodin, emodin, chrysarobin, isochrysophanol), flavonoids (kaempferol, quercetin, luteolin, chrysoeriol), flavonoid glycosides (quercetin 3-rhamnoside-7-glucoside), tannins, saponins, alkaloids, and the aglycone β-sitosterol-β-D-glucoside. GC-MS analysis identified 88 total phytochemicals including fatty acids (n-hexadecanoic/palmitic acid, stearic acid, oleic acid, linoleic acid), the diterpene alcohol neophytadiene, and essential oil constituents linalool (23.0%), borneol (8.6%), and pentadecanal (9.3%). Bioavailability of anthraquinone glycosides is influenced by gut microbiome hydrolysis to their active aglycone forms, and polyphenol absorption may be enhanced by co-consumption with lipid-containing foods given the lipophilic character of compounds such as chrysophanol.

Preparation & Dosage

- **Fresh Leaf Poultice (Traditional Topical)**: Leaves are crushed or bruised and applied directly to affected skin areas (tinea, ringworm) 1–2 times daily; this is the most documented Jamu preparation and aligns with the plant's antifungal phytochemistry.
- **Leaf Decoction (Traditional Oral)**: Approximately 15–30 g of fresh leaves boiled in 500 mL water, strained, and consumed as a tea 1–2 times daily for inflammatory or infectious conditions in Southeast Asian folk medicine.
- **Methanol/Ethanol Leaf Extract (Research-Grade)**: Concentrations of 28.50–54 μg/mL have been used in antioxidant assays; no standardized commercial supplement dose has been established for human use.
- **Hexane Extract (Antidiabetic Research)**: IC₅₀ of 0.85 mg/mL for α-glucosidase inhibition was determined in vitro; translatable human doses have not been established through clinical pharmacokinetic studies.
- **Essential Oil**: Linalool (23.0%), borneol (8.6%), and pentadecanal (9.3%) are major constituents; used in topical aromatherapy applications, though standardized dosage guidance is absent.
- **Standardization**: No commercial standardization percentages (e.g., percentage chrysophanol or kaempferol) have been formally adopted; research extracts vary widely by solvent polarity and plant part used.
- **Timing**: Traditional topical application is performed twice daily until lesion resolution; no human pharmacokinetic data exist to inform timing of oral preparations.

Synergy & Pairings

Cassia alata's antifungal activity may be synergistically enhanced when combined with other anthraquinone-rich or terpenoid-containing botanicals such as neem (Azadirachta indica) leaf extract, as both target fungal membrane integrity through complementary mechanisms—anthraquinone-mediated membrane disruption and terpenoid-mediated ergosterol interference. Its α-glucosidase inhibitory compounds (kaempferol, emodin) may work synergistically with berberine (from Berberis species), which inhibits α-glucosidase through a distinct allosteric site while also activating AMPK, providing dual-pathway postprandial glucose management. The antioxidant polyphenols quercetin and kaempferol in Cassia alata are known to exhibit synergy with vitamin C (ascorbic acid), which regenerates oxidized flavonoid radicals back to their active reduced form, potentially extending the effective antioxidant duration of leaf preparations.

Safety & Interactions

Acute cytotoxicity testing in brine shrimp lethality assays found ethanolic leaf extract LC₅₀ > 1000 μg/mL, suggesting low acute toxicity, but comprehensive human safety data—including chronic-use adverse event profiles, dose-finding, and organ toxicity studies—are absent from the published literature. The anthraquinone constituents (emodin, aloe-emodin, chrysophanol) are structurally related to anthraquinone laxatives (e.g., senna glycosides) and may cause gastrointestinal cramping, diarrhea, and electrolyte disturbances at higher oral doses; prolonged oral anthraquinone exposure has been associated with melanosis coli and, in high doses, nephrotoxicity in animal studies. Potential drug interactions include additive hypoglycemic effects when combined with oral antidiabetic agents (metformin, sulfonylureas, DPP-4 inhibitors) given documented α-glucosidase inhibition, and possible potentiation of anticoagulants given modest thrombolytic activity observed in vitro. Pregnancy and lactation use is not recommended due to the presence of anthraquinone glycosides, which are uterotonic and excreted in breast milk in related Cassia/Senna species; no maximum safe human dose has been formally established.